报告儿童牙科随机对照试验摘要的质量报告
Vellore Kannan Gopinath1, Raghavendra M Shetty2,3,4, Apathsakayan Renugalakshmi5,6
1University of Sharjah, College of Dental Medicine, Department of Preventive and Restorative Dentistry, Sharjah, United Arab Emirates.
European journal of dentistry
|August 8, 2023
概括
儿科牙科随机对照试验摘要往往缺乏足够的报告质量,未能完全遵守综合报告试验标准 (CONSORT) 的摘要指南. 提高坚持可以提高读者的总体抽象质量和清晰度.
科学领域:
- 儿科牙科 儿科牙科
- 临床研究报告报告
背景情况:
- 随机对照试验 (RCT) 摘要的报告质量对于传播研究结果至关重要.
- 对摘要的综合报告试验标准 (CONSORT) 提供了提高摘要清晰度和完整性的指导方针.
研究的目的:
- 系统地评估儿童牙科中RCT摘要的报告质量,使用CONSORT摘要检查清单.
- 确定与这些摘要质量相关的因素.
主要方法:
- 研究人员对2016年至2021年在"儿科牙科"杂志上发表的RCT摘要进行了系统审查.
- 两个独立审稿人使用CONSORT的摘要检查清单来评估摘要质量.
- 统计分析包括描述性统计,曼-惠特尼U测试和克鲁斯卡尔-瓦利斯测试.
主要成果:
- 分析了200个摘要,其中"客观"是报告最好的项目.
- "随机化"和"伤害"分别在98%和96%的摘要中报告不足.
- 摘要质量与作者的大陆,作者数量,影响因子,遵守CONSORT,字数,研究重点和协议注册有显著联系.
结论:
- 儿科牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示,儿童牙科的RCT摘要显示.
- 平均报告分数为15分之6.80,这表明有很大的改进空间.
- 实施CONSORT指南可以提高现场公布的RCT摘要的质量和透明度.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Hazard Ratio
158
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
158
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


